Morgan Stanley Optimize Rx Corp Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Optimize Rx Corp stock. As of the latest transaction made, Morgan Stanley holds 149,715 shares of OPRX stock, worth $796,483. This represents 0.0% of its overall portfolio holdings.

Number of Shares

149,715

Previous 98,864 51.44%

Holding current value

$796,483

Previous $988,000 16.9%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.2 - $11.23 $366,127 - $571,056	50,851 Added 51.44%	149,715 $1.16 Million
Q2 2024 Oct 17, 2024	BUY	$8.8 - $13.17 $218,759 - $327,393	24,859 Added 33.59%	98,864 $988,000
Q2 2024 Aug 14, 2024	BUY	$8.8 - $13.17 $218,759 - $327,393	24,859 Added 33.59%	98,864 $988,000
Q1 2024 Oct 17, 2024	SELL	$11.47 - $16.17 $285,132 - $401,970	-24,859 Reduced 25.14%	74,005 $899,000
Q1 2024 Aug 16, 2024	SELL	$11.47 - $16.17 $44,996 - $63,434	-3,923 Reduced 5.03%	74,005 $899,000
Q1 2024 May 15, 2024	SELL	$11.47 - $16.17 $44,996 - $63,434	-3,923 Reduced 5.03%	74,005 $899,000
Q4 2023 Aug 16, 2024	SELL	$7.06 - $14.49 $147,808 - $303,362	-20,936 Reduced 21.18%	77,928 $1.12 Million
Q4 2023 Feb 13, 2024	BUY	$7.06 - $14.49 $212,943 - $437,047	30,162 Added 63.15%	77,928 $1.12 Million
Q3 2023 Nov 15, 2023	BUY	$7.43 - $14.96 $148,637 - $299,274	20,005 Added 72.06%	47,766 $371,000
Q2 2023 Aug 14, 2023	SELL	$11.63 - $15.63 $1.16 Million - $1.56 Million	-99,576 Reduced 78.2%	27,761 $396,000
Q1 2023 May 15, 2023	SELL	$12.54 - $19.38 $546,493 - $844,580	-43,580 Reduced 25.5%	127,337 $1.86 Million
Q4 2022 Feb 14, 2023	SELL	$13.77 - $22.04 $427,310 - $683,945	-31,032 Reduced 15.37%	170,917 $2.87 Million
Q3 2022 Nov 14, 2022	BUY	$13.74 - $30.13 $480,501 - $1.05 Million	34,971 Added 20.94%	201,949 $2.99 Million
Q2 2022 Oct 27, 2022	BUY	$21.94 - $40.49 $139,165 - $256,828	6,343 Added 3.95%	166,978 $4.57 Million
Q2 2022 Aug 15, 2022	BUY	$21.94 - $40.49 $139,165 - $256,828	6,343 Added 3.95%	166,978 $4.57 Million
Q1 2022 Oct 27, 2022	SELL	$35.27 - $62.91 $223,717 - $399,038	-6,343 Reduced 3.8%	160,635 $6.06 Million
Q1 2022 May 13, 2022	SELL	$35.27 - $62.91 $997,964 - $1.78 Million	-28,295 Reduced 14.98%	160,635 $6.06 Million
Q4 2021 Feb 14, 2022	BUY	$53.57 - $98.0 $8.81 Million - $16.1 Million	164,498 Added 673.29%	188,930 $11.7 Million
Q3 2021 Nov 15, 2021	BUY	$50.93 - $85.55 $1.24 Million - $2.09 Million	24,432 New	24,432 $2.09 Million

Others Institutions Holding OPRX

# of Institutions

Shares Held

12.2M

Call Options Held

800

Put Options Held

18.1K

View Full List

About OptimizeRx Corp

Ticker OPRX
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 18,023,100
Market Cap $95.9M
Description
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...

More about OPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account